vs

Side-by-side financial comparison of MYRIAD GENETICS INC (MYGN) and Rubrik, Inc. (RBRK). Click either name above to swap in a different company.

Rubrik, Inc. is the larger business by last-quarter revenue ($350.2M vs $209.8M, roughly 1.7× MYRIAD GENETICS INC). On growth, Rubrik, Inc. posted the faster year-over-year revenue change (48.3% vs -0.4%).

Myriad Genetics, Inc. is an American genetic testing and precision medicine company based in Salt Lake City, Utah, United States. Myriad employs a number of proprietary technologies that permit doctors and patients to understand the genetic basis of human disease and the role that genes play in the onset, progression and treatment of disease. This information is used to guide the development of new products that assess an individual's risk for developing disease later in life, identify a pati...

Rubrik, Inc. is an American cloud data management and data security company based in Palo Alto, California, founded in January 2014. The company is listed on the New York Stock Exchange after going public in April 2024.

MYGN vs RBRK — Head-to-Head

Bigger by revenue
RBRK
RBRK
1.7× larger
RBRK
$350.2M
$209.8M
MYGN
Growing faster (revenue YoY)
RBRK
RBRK
+48.6% gap
RBRK
48.3%
-0.4%
MYGN

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
MYGN
MYGN
RBRK
RBRK
Revenue
$209.8M
$350.2M
Net Profit
$-63.8M
Gross Margin
70.0%
80.5%
Operating Margin
-2.7%
-21.6%
Net Margin
-18.2%
Revenue YoY
-0.4%
48.3%
Net Profit YoY
51.2%
EPS (diluted)
$-0.09
$-0.32

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MYGN
MYGN
RBRK
RBRK
Q4 25
$209.8M
$350.2M
Q3 25
$205.7M
$309.9M
Q2 25
$213.1M
$278.5M
Q1 25
$195.9M
$258.1M
Q4 24
$210.6M
$236.2M
Q3 24
$213.3M
$205.0M
Q2 24
$211.5M
$187.3M
Q1 24
$202.2M
Net Profit
MYGN
MYGN
RBRK
RBRK
Q4 25
$-63.8M
Q3 25
$-27.4M
$-95.9M
Q2 25
$-330.5M
$-102.1M
Q1 25
$-100.0K
$-114.9M
Q4 24
$-130.9M
Q3 24
$-22.1M
$-176.9M
Q2 24
$-36.7M
$-732.1M
Q1 24
$-26.0M
Gross Margin
MYGN
MYGN
RBRK
RBRK
Q4 25
70.0%
80.5%
Q3 25
69.9%
79.5%
Q2 25
71.2%
78.3%
Q1 25
68.5%
77.4%
Q4 24
71.7%
76.2%
Q3 24
70.2%
73.1%
Q2 24
69.6%
48.8%
Q1 24
68.1%
Operating Margin
MYGN
MYGN
RBRK
RBRK
Q4 25
-2.7%
-21.6%
Q3 25
-11.3%
-30.5%
Q2 25
-154.5%
-33.4%
Q1 25
-14.8%
-45.0%
Q4 24
-18.6%
-52.8%
Q3 24
-9.4%
-82.1%
Q2 24
-17.3%
-387.0%
Q1 24
-13.8%
Net Margin
MYGN
MYGN
RBRK
RBRK
Q4 25
-18.2%
Q3 25
-13.3%
-31.0%
Q2 25
-155.1%
-36.7%
Q1 25
-0.1%
-44.5%
Q4 24
-55.4%
Q3 24
-10.4%
-86.3%
Q2 24
-17.4%
-390.8%
Q1 24
-12.9%
EPS (diluted)
MYGN
MYGN
RBRK
RBRK
Q4 25
$-0.09
$-0.32
Q3 25
$-0.29
$-0.49
Q2 25
$-3.57
$-0.53
Q1 25
$0.00
$5.69
Q4 24
$-0.47
$-0.71
Q3 24
$-0.24
$-0.98
Q2 24
$-0.41
$-11.48
Q1 24
$-0.29

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MYGN
MYGN
RBRK
RBRK
Cash + ST InvestmentsLiquidity on hand
$149.6M
$307.1M
Total DebtLower is stronger
$119.9M
Stockholders' EquityBook value
$368.0M
$-524.4M
Total Assets
$706.6M
$2.5B
Debt / EquityLower = less leverage
0.33×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MYGN
MYGN
RBRK
RBRK
Q4 25
$149.6M
$307.1M
Q3 25
$145.4M
$322.7M
Q2 25
$74.4M
$284.0M
Q1 25
$91.8M
$186.3M
Q4 24
$102.4M
$103.9M
Q3 24
$99.9M
$142.3M
Q2 24
$97.3M
$502.6M
Q1 24
$104.3M
Total Debt
MYGN
MYGN
RBRK
RBRK
Q4 25
$119.9M
Q3 25
$119.5M
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
MYGN
MYGN
RBRK
RBRK
Q4 25
$368.0M
$-524.4M
Q3 25
$372.8M
$-564.3M
Q2 25
$388.1M
$-556.5M
Q1 25
$704.9M
$-553.7M
Q4 24
$701.1M
$-521.1M
Q3 24
$731.7M
$-499.3M
Q2 24
$740.5M
$-514.6M
Q1 24
$760.0M
Total Assets
MYGN
MYGN
RBRK
RBRK
Q4 25
$706.6M
$2.5B
Q3 25
$728.1M
$2.4B
Q2 25
$677.3M
$1.5B
Q1 25
$1.0B
$1.4B
Q4 24
$1.0B
$1.3B
Q3 24
$1.1B
$1.2B
Q2 24
$1.1B
$1.2B
Q1 24
$1.1B
Debt / Equity
MYGN
MYGN
RBRK
RBRK
Q4 25
0.33×
Q3 25
0.32×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MYGN
MYGN
RBRK
RBRK
Operating Cash FlowLast quarter
$10.6M
$85.5M
Free Cash FlowOCF − Capex
$80.7M
FCF MarginFCF / Revenue
23.1%
Capex IntensityCapex / Revenue
1.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$256.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MYGN
MYGN
RBRK
RBRK
Q4 25
$10.6M
$85.5M
Q3 25
$21.1M
$64.7M
Q2 25
$-13.6M
$39.7M
Q1 25
$-16.3M
$83.6M
Q4 24
$6.6M
$23.1M
Q3 24
$700.0K
$-27.1M
Q2 24
$2.6M
$-31.4M
Q1 24
$-18.6M
Free Cash Flow
MYGN
MYGN
RBRK
RBRK
Q4 25
$80.7M
Q3 25
$61.2M
Q2 25
$36.8M
Q1 25
$78.0M
Q4 24
$18.0M
Q3 24
$-29.7M
Q2 24
$-35.0M
Q1 24
FCF Margin
MYGN
MYGN
RBRK
RBRK
Q4 25
23.1%
Q3 25
19.8%
Q2 25
13.2%
Q1 25
30.2%
Q4 24
7.6%
Q3 24
-14.5%
Q2 24
-18.7%
Q1 24
Capex Intensity
MYGN
MYGN
RBRK
RBRK
Q4 25
1.4%
Q3 25
1.1%
Q2 25
1.0%
Q1 25
2.2%
Q4 24
2.1%
Q3 24
1.3%
Q2 24
1.9%
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MYGN
MYGN

Segment breakdown not available.

RBRK
RBRK

Subscription And Circulation$336.4M96%
Other$12.3M4%
Software And Services$4.9M1%
Maintenance$1.5M0%

Related Comparisons